Table 2.
Representative cell surface markers for human cancer stem cells
| Type of cancer stem cells | Cell surface markers |
|---|---|
| Acute myelogenous leukemia; | CD34+, CD38-, CD44, CD123+ |
| Chronic myeloid leukemia | CD34+, CD38-, CD123+ |
| B-acute lymphogenous leukemia | CD34+, CD38-, CD19+ |
| Ph1-acute lymphogenous leukemia | CD34+, CD38- |
| Blast-crisis CML | CD34+, CD38+, CD123+ |
| Myeloproliferative disorder | CD117+ |
| Glioblastoma | CD133+ |
| Medulloblastoma | CD133+ |
| Pilocytic astrocytoma | CD133+ |
| Anaplastic ependymoma | CD133+ |
| Breast | CD44+, CD24-/low, ESA+ |
| Prostate | CD133+/alpha 2 beta 1 integrin/CD44+ CD44+/CD24- |
| Ovarian cancer | CD44+, MyD88+ |
| Colon cancer | CD133+, CD44+, CD166+, E-CAMhig |
| Pancreatic cancer | CD133+, CD44+, CD24+ |
| Hepatocellular cancer | CD133+ |
| Head and neck squamous cell carcinoma | CD44+ |
| Bone sarcomas | Stro-1+, CD105+, CD44+ |
| Melanoma | CD20+, CD133+ |
| Lung cancer | CD133+ |
| Liver | CD133+, CD90+ |
| Central nervous system | CD133+ |